Halthcare Analysts discuss the patiet community perspective on Friedreich’s Ataxia (relevant companies LRMR BIB PTCT LXEO DSGN) on an Analyst/Industry conference call to be held on October 3.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LRMR:
- 3 Best Stocks to Buy Now, 9/30/2025, According to Top Analysts
- Larimar Therapeutics price target lowered to $7 from $10 at Baird
- Buy Rating for Larimar Therapeutics Driven by Promising Data and Unmet Need in Friedreich’s Ataxia
- EA acquired in go-private deal for $55B, Carnival reports Q3 beat: Morning Buzz
- Optimistic Buy Rating for Larimar Therapeutics Amid Promising Data and Safety Adjustments